Xcout Intel
Alessa Therapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Alessa Therapeutics, Inc. among therapeutics companies — ranked by similarity to what Alessa Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see Alessa Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Alessa Therapeutics, Inc.
Alessa Therapeutics, Inc. is a clinical-stage biotechnology and drug development company headquartered in San Carlos, California, pioneering innovative localized treatments for solid tumors.
Alessa Therapeutics, Inc. at a glance
Alessa Therapeutics, Inc. is a therapeutics company headquartered in United States. It has raised at least $31.6M across the 3 funding rounds on record. Its most recent funding round raised $25.4M in April 2025. Xcout tracks 16 named people at Alessa Therapeutics, Inc., including Cam Gallagher (President & Chief Executive Officer).
Alessa Therapeutics, Inc. leadership
- Cam GallagherPresident & Chief Executive Officer
- May HanChief Operating Officer
- Maithili RairkarChief Technical Officer, Head of CMC
- Zach CollinsChief Business Officer
- Dr. Neal ShoreCo-Chairperson
- Dr. Peter CarrollCo-Chairperson
10 more named people on record for Alessa Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Alessa Therapeutics, Inc. funding rounds
At least $31.6M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $25.4M | — | |
| SEC Form D filing | $3.3M | — | |
| SEC Form D filing | $3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Alessa Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to Alessa Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Cybrexa Therapeutics is a clinical-stage oncology biotechnology company that develops tumor-targeting peptide-drug conjugates (PDCs) for cancer patients. Its proprietary alphalex technology uses a pH-driven approach for antigen-independent, intracellular delivery of anti-cancer agents directly to tumors and metastases.
Biotech
RenovoRx, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing therapies for solid tumor malignancies. The company's primary investigational therapy, RenovoGem, is an innovative drug and device combination. It integrates intra-arterial gemcitabine with the RenovoCath system, currently progressing through pivotal Phase III clinical trials for the treatment of locally advanced pancreatic cancer. Established in 2009, RenovoRx, Inc. maintains its headquarters in Los Altos, California.
Biotech
Azalea Therapeutics is a biotechnology company headquartered in Berkeley, California. The company focuses on precision genome engineering directly inside the body with an initial emphasis on developing in vivo cancer immunotherapies.
Biotechnology
Aperture Therapeutics is a biotechnology research company founded in 2022 and headquartered in San Carlos, California. The company is building an innovative drug discovery platform that leverages patient genetic diversity and mechanistic insights.
Biotechnology
Ankyra Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts. The company develops localized immune-mediated therapies for the treatment of cancer.
Biotech
Aprea Therapeutics, Inc. is a biopharmaceutical company in its clinical development stage, dedicated to discovering and marketing innovative cancer treatments. Their therapeutic approach centers on modulating DNA damage response pathways. The company's primary drug candidate, ATRN-119, is an oral ATR inhibitor currently undergoing Phase 1/2a clinical trials for patients with advanced solid tumors. Beyond this lead compound, Aprea's developmental pipeline includes ATRN-Backup, which is also an ATR inhibitor; ATRN-W1051, being explored for its anti-tumor effects; and ATRN-DDRi. Aprea Therapeutics, Inc. is headquartered in Boston, Massachusetts.
Biotechnology
A2 Biotherapeutics, Inc. is a clinical-stage biotechnology research company headquartered in Agoura Hills, California. The company develops precision T-cell therapies designed to target solid tumors while sparing healthy tissue.
Medical Technology
Alpheus Medical, Inc. is a privately held biotechnology company based in Chanhassen, Minnesota, focused on developing an investigational therapy that pairs a tumor-accumulating drug with ultrasound.
Healthcare
Forty Seven, Inc. is a clinical-stage immuno-oncology company headquartered in Menlo Park, California, that develops therapies targeting cancer immune evasion pathways.
Biotechnology
Alterome Therapeutics, Inc. is a clinical-stage precision oncology company headquartered in San Diego, California, founded in 2021. The privately held biotech firm focuses on developing targeted therapies to address genomically defined cancer drivers and intractable oncological targets.
Biotech
Elicera Therapeutics is a clinical-stage immuno-oncology company that develops genetically engineered cell and gene therapies, including CAR T-cell therapies and oncolytic viruses, to treat various types of cancer. The company utilizes its proprietary iTANK technology platform to enhance the immune system's ability to target and attack solid tumors.
Biotech
Rakuten Medical, Inc. is a global biotechnology company headquartered in San Diego, California, that develops precision, cell-targeting investigational therapies using its proprietary Alluminox technology platform.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Alessa Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Alessa Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →